Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. (2021)
Attributed to:
Innovative Technologies for Stratified and Experimental Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-21-1499
PubMed Identifier: 34625424
Publication URI: http://europepmc.org/abstract/MED/34625424
Type: Journal Article/Review
Volume: 81
Parent Publication: Cancer research
Issue: 23
ISSN: 0008-5472